Equinome
Dublin
About Equinome
Equinome, a spin out from UCD was incorporated in May 2009. The technology was developed in Dr. Emmeline Hill’s laboratory in UCD. Equinome is a world leader in the development and provision of genomic selection tools for the bloodstock and racing industry. The product, ’The Speed Gene test‘ genetically identifies (through a blood test) whether a racehorse will be more suited as a short, medium or long distance runner. It will influence the breeding strategies of farms who will select certain mares and stallions to produce progeny with desired genetic profiles for particular racing distances. The company was co-founded by Dr. Hill and Mr. Jim Bolger, the renowned Irish horse breeder. Still in its first year of operation, Equinome has already secured customers in Ireland, UK, France, USA, Australia, New Zealand and Singapore.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2015)
- Website: equinome.com
- Phone: +353 (0)1 716 3775
Industries & Categories
Biotechnology, Genetics, Innovation Management, Search Engine
Social Profiles
Canonical: https://fsome.com/organization/equinome-2278564 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.